Myocardial infarction in the elderly. Clinical and therapeutic differences

Kardiologia Polska

Volumn 66, Issue 2, 2008, Pages 166-172

  Polewczyk, Anna ^a,d   Janion, Marianna ^a,b   Ga̧sior, Mariusz ^c   Gierlotka, Marek ^c  

^a Regional District Hospital   (Poland)

^b JAN KOCHANOWSKI UNIVERSITY   (Poland)

^c MEDICAL UNIVERSITY OF SILESIA   (Poland)

^d Swietokrzyskie Centrum Kardiologii Poland   (Poland)

Author keywords

Elderly; Myocardial infarction; Reperfusion therapy

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL FEATURE; DIABETES MELLITUS; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REPERFUSION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SYMPTOMATOLOGY; AGING; COMPARATIVE STUDY; HEART INFARCTION; MIDDLE AGED;

ADULT; AGED; AGING; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 50049083388     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. nd edn, Merck Research Laboratoires, New York 1995; 429-441; 1351-63.
2. Świa̧tecka G. Kardiologia starszego wieku. Via Medica, Gdańsk 1997; 1-5.
3. Thom T, Haase N, Rosamond W, et al. Heart disease and stroke statistics - 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006; 113: e85-e151.
4. Kotowska I. Wybrane wyniki prognozy stanu i struktury ludności Polski. In: Wóycicka I (ed.). Strategia polityki społecznej 1999-2020. Instytut badań nad Gospodarka̧ Rynkowa̧. Warszawa 1999; 15-24.
5. Kates AM, Herrero P, Dence C, et al. Impact of aging on substrate metabolism by the human heart. J Am Coll Cardiol 2003; 41: 293-9.
6. Folkow B, Karlström G. Age- and pressure-dependent changes of systemic resistance vessels concerning the relationships between geometric design, wall distensibility, vascular reactivity and smooth muscle sensitivity. Acta Physiol Scand 1984; 122: 17-33.
7. Vanhoutte PM. Endothelium and control of vascular function. State of the Art lecture. Hypertension 1989; 13: 658-67.
8. Mehta RH, Rathore SS, Radford MJ, et al. Acute myocardial infarction in the elderly: differences by age. J Am Coll Cardiol 2001; 38: 736-41.
9. Miller PF, Sheps DS, Bragdon EE, et al. Aging and pain perception in ischemic heart disease. Am Heart J 1990; 120: 22-30.
10. Sheifer SE, Rathore SS, Gersh BJ, et al. Time to presentation with acute myocardial infarction in the elderly: associations with race, sex, and socioeconomic characteristics. Circulation 2000; 102: 1651-6.
11. Alexander KP, Galanos AN, Jollis JG, et al. Post-myocardial infarction risk stratification in elderly patients. Am Heart J 2001; 142: 37-42.
12. De Luca G, van 't Hof AW, Ottervanger JP, et al. Ageing, impaired myocardial perfusion, and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty. Eur Heart J 2005; 26: 662-6.
13. Eritsland J, Klow NE, Westheim A, et al. Primary angioplasty in acute ST elevation myocardial infarction in the elderly. Tidsskr Nor Laegeforen 2005; 125: 2922-4.
14. Zeymer U, Gitt A, Winkler R. Mortality of patients who are older than 75 years after ST elevation myocardial infarction in clinical practice. Dtsch Med Wochenschr 2005; 130: 633-6.
15. Zhang Q, Zhang RY, Zhang JS, et al. Outcomes of primary percutaneous coronary intervention for acute ST-elevation myocardial infarction in patients aged over 75 years. Chin Med J (Engl) 2006; 119: 1151-6.
16. McLaughlin TJ, Soumerai SB, Willison DJ, et al. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly. Arch Intern Med 1996; 156: 799-805.
17. Janion M. Różnice w przebiegu klinicznym zawału serca i rokowaniu odległym w trzech grupach wiekowych. Pol Przegl Kardiol 1999; 1: 121-8.
18. Baigent C, Collins R, Appleby P, et al. SIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. BMJ 1998; 316: 1337-43.
19. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 71-86.